We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
-3.4%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$18.2B
AUM Growth
-$235M
Cap. Flow
-$283M
Cap. Flow %
-1.55%
Top 10 Hldgs %
32.02%
Holding
333
New
17
Increased
37
Reduced
36
Closed
22

Sector Composition

Rank Sector Weight
1 Healthcare 28.16%
2 Technology 19.07%
3 Financials 13.73%
4 Industrials 8.28%
5 Communication Services 8.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GBT
76
DELISTED
Global Blood Therapeutics, Inc.
GBT
$30.6M 0.17%
+450,000
New +$24.8M
GATE
77
DELISTED
Marblegate Acquisition Corp. Class A Common Stock
GATE
$29.6M 0.16%
2,970,000
KVSC
78
DELISTED
Khosla Ventures Acquisition Co. III Class A Common Stock
KVSC
$27.5M 0.15%
2,809,000
BRMK
79
DELISTED
Broadmark Realty Capital Inc. Common Stock
BRMK
$24.8M 0.14%
4,850,000
AUS
80
DELISTED
Austerlitz Acquisition Corporation I
AUS
$24.5M 0.13%
2,500,000
MTAL
81
DELISTED
Metals Acquisition
MTAL
$24.4M 0.13%
2,489,700
BACA
82
DELISTED
Berenson Acquisition Corp. I
BACA
$24.4M 0.13%
2,475,000
ISEE
83
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$23.6M 0.13%
+1,317,000
New +$17.3M
TVRD
84
Tvardi Therapeutics
TVRD
$23.4M
$23.4M 0.13%
69,444
IVCP
85
DELISTED
Swiftmerge Acquisition Corp. Class A Ordinary Share
IVCP
$19.7M 0.11%
1,980,000
REVH
86
DELISTED
Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock
REVH
$19.7M 0.11%
2,000,000
LUNR icon
87
Intuitive Machines
LUNR
$2.63B
$18.7M 0.1%
1,900,000
KRTX
88
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$18M 0.1%
80,000
-20,000
-20% -$4.05M
AMRS
89
DELISTED
Amyris Inc.
AMRS
$17.9M 0.1%
6,126,642
-15,083,240
-71% -$41.1M
AUY
90
DELISTED
Yamana Gold, Inc.
AUY
$17.7M 0.1%
+3,900,000
New +$18.1M
SEPA
91
DELISTED
SEP Acquisition Corp Class A Common Stock
SEPA
$17.3M 0.09%
1,732,500
FVIV
92
DELISTED
Fortress Value Acquisition Corp. IV
FVIV
$17.2M 0.09%
1,750,000
SEDA
93
DELISTED
SDCL EDGE Acquisition Corporation
SEDA
$17.1M 0.09%
1,732,500
TGNA
94
DELISTED
TEGNA Inc
TGNA
$17.1M 0.09%
825,000
-375,000
-31% -$7.94M
VAQC
95
DELISTED
Vector Acquisition Corporation II Class A Ordinary Shares
VAQC
$16.9M 0.09%
1,700,000
SHQA
96
DELISTED
Shelter Acquisition Corporation I Class A Common Stock
SHQA
$16.4M 0.09%
1,650,000
SVRA icon
97
Savara
SVRA
$1.19B
$15.4M 0.08%
9,908,086
+330,813
+3% +$533K
BSKY
98
DELISTED
Big Sky Growth Partners, Inc. Class A Common Stock
BSKY
$15.2M 0.08%
1,550,000
KAHC
99
DELISTED
KKR Acquisition Holdings I Corp.
KAHC
$14.8M 0.08%
1,500,000
ASZ
100
DELISTED
Austerlitz Acquisition Corporation II
ASZ
$14.7M 0.08%
1,500,000

Similar funds

Farallon Capital Management's Q3 2022 Portfolio in Review

As of Q3 2022, Farallon Capital Management held 333 positions worth $18.2B, down 1.3% from $18.4B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Farallon Capital Management's Q3 2022 filing shows 17 new, 37 increased, 36 reduced and 22 closed positions. Its largest new stake was Humana: 251,200 shares worth $122M. The largest sale was Coherent Inc, an estimated $154M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 31% a quarter earlier, followed by Technology and Financials.

  • Farallon Capital Management's largest Q3 2022 buy was Humana: 251,200 shares worth $122M.
  • Farallon Capital Management added most to ZENDESK INC in Q3 2022, an estimated $262M increase.
  • Farallon Capital Management's biggest Q3 2022 reduction was Howmet Aerospace, cutting an estimated $140M.
  • Farallon Capital Management fully exited Coherent Inc in Q3 2022, selling an estimated $154M.
  • Farallon Capital Management's ten largest holdings make up 32% of its $18.2B portfolio in Q3 2022.
  • Farallon Capital Management opened 17 new positions and closed 22 in Q3 2022.
  • Farallon Capital Management's portfolio value fell 1.3% quarter-over-quarter to $18.2B.

Based on Farallon Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.